JP2020527574A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020527574A5 JP2020527574A5 JP2020502343A JP2020502343A JP2020527574A5 JP 2020527574 A5 JP2020527574 A5 JP 2020527574A5 JP 2020502343 A JP2020502343 A JP 2020502343A JP 2020502343 A JP2020502343 A JP 2020502343A JP 2020527574 A5 JP2020527574 A5 JP 2020527574A5
- Authority
- JP
- Japan
- Prior art keywords
- joint
- pharmaceutical composition
- items
- knee
- cooling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims description 271
- 238000001816 cooling Methods 0.000 claims description 227
- 210000003127 knee Anatomy 0.000 claims description 137
- 229960002504 capsaicin Drugs 0.000 claims description 132
- 235000017663 capsaicin Nutrition 0.000 claims description 132
- 239000008194 pharmaceutical composition Substances 0.000 claims description 132
- 239000012530 fluid Substances 0.000 claims description 93
- 208000006820 Arthralgia Diseases 0.000 claims description 69
- 210000001519 tissue Anatomy 0.000 claims description 63
- 238000002347 injection Methods 0.000 claims description 56
- 239000007924 injection Substances 0.000 claims description 56
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims description 51
- 229960004194 lidocaine Drugs 0.000 claims description 51
- 210000000629 knee joint Anatomy 0.000 claims description 38
- 201000008482 osteoarthritis Diseases 0.000 claims description 37
- 206010006784 Burning sensation Diseases 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 33
- 230000001052 transient effect Effects 0.000 claims description 33
- 208000002193 Pain Diseases 0.000 claims description 31
- 238000002560 therapeutic procedure Methods 0.000 claims description 24
- 229940124641 pain reliever Drugs 0.000 claims description 21
- 150000003839 salts Chemical class 0.000 claims description 21
- 239000003589 local anesthetic agent Substances 0.000 claims description 17
- 239000002826 coolant Substances 0.000 claims description 11
- 230000003467 diminishing effect Effects 0.000 claims description 10
- 230000000007 visual effect Effects 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 3
- 230000003349 osteoarthritic effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 description 409
- -1 Polyethylene Polymers 0.000 description 27
- 229920001223 polyethylene glycol Polymers 0.000 description 27
- 210000001872 metatarsal bone Anatomy 0.000 description 26
- 208000005890 Neuroma Diseases 0.000 description 25
- 239000004698 Polyethylene Substances 0.000 description 23
- 239000002202 Polyethylene glycol Substances 0.000 description 23
- 125000000350 glycoloyl group Chemical group O=C([*])C([H])([H])O[H] 0.000 description 23
- 229920000573 polyethylene Polymers 0.000 description 23
- 239000002904 solvent Substances 0.000 description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
- 238000009472 formulation Methods 0.000 description 12
- 210000001503 joint Anatomy 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000003607 modifier Substances 0.000 description 9
- 230000003204 osmotic effect Effects 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 8
- 239000002738 chelating agent Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 210000002683 foot Anatomy 0.000 description 6
- 208000004296 neuralgia Diseases 0.000 description 5
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical group CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- YKPUWZUDDOIDPM-VURMDHGXSA-N zucapsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C/C(C)C)=CC=C1O YKPUWZUDDOIDPM-VURMDHGXSA-N 0.000 description 3
- 229960002860 zucapsaicin Drugs 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 210000000544 articulatio talocruralis Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 210000003797 carpal joint Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000002310 elbow joint Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000001483 monosaccharide substituent group Chemical group 0.000 description 1
- 150000002894 organic compounds Chemical group 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 210000000323 shoulder joint Anatomy 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023081213A JP7738031B2 (ja) | 2017-07-20 | 2023-05-17 | カプサイシンを使用した疼痛の治療のための方法及び組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762535003P | 2017-07-20 | 2017-07-20 | |
| US62/535,003 | 2017-07-20 | ||
| PCT/US2018/043094 WO2019018769A1 (en) | 2017-07-20 | 2018-07-20 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN USING CAPSAICINE |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023081213A Division JP7738031B2 (ja) | 2017-07-20 | 2023-05-17 | カプサイシンを使用した疼痛の治療のための方法及び組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020527574A JP2020527574A (ja) | 2020-09-10 |
| JP2020527574A5 true JP2020527574A5 (https=) | 2021-08-26 |
| JP7282736B2 JP7282736B2 (ja) | 2023-05-29 |
Family
ID=65016186
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502343A Active JP7282736B2 (ja) | 2017-07-20 | 2018-07-20 | カプサイシンを使用した疼痛の治療のための方法及び組成物 |
| JP2023081213A Active JP7738031B2 (ja) | 2017-07-20 | 2023-05-17 | カプサイシンを使用した疼痛の治療のための方法及び組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023081213A Active JP7738031B2 (ja) | 2017-07-20 | 2023-05-17 | カプサイシンを使用した疼痛の治療のための方法及び組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US20200206166A1 (https=) |
| EP (1) | EP3654961B1 (https=) |
| JP (2) | JP7282736B2 (https=) |
| CN (1) | CN111201015A (https=) |
| AU (1) | AU2018302342B2 (https=) |
| BR (1) | BR112020000989A2 (https=) |
| CA (1) | CA3069540A1 (https=) |
| ES (1) | ES3018268T3 (https=) |
| IL (1) | IL272036B2 (https=) |
| MX (1) | MX2020000488A (https=) |
| WO (1) | WO2019018769A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019018769A1 (en) * | 2017-07-20 | 2019-01-24 | Centrexion Therapeutics Corporation | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN USING CAPSAICINE |
| EP3840739B1 (en) * | 2018-08-24 | 2025-11-12 | Centrexion Therapeutics Corporation | Capsaicin sequential dosing method for treatment of knee joint pain |
| CN114028540B (zh) * | 2021-11-26 | 2023-10-17 | 海南鑫开源医药科技有限公司 | 一种具有镇痛作用的组合物、微针贴片及其制备方法以及应用 |
| CN115006379B (zh) * | 2021-12-28 | 2023-12-15 | 南京清普生物科技有限公司 | 一种trpv1激动剂原位膜剂组合物，及其制备方法和用途 |
| EP4593867A2 (en) * | 2022-09-30 | 2025-08-06 | Extend Biosciences, Inc. | Long-acting parathyroid hormone |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599342A (en) | 1984-01-16 | 1986-07-08 | The Procter & Gamble Company | Pharmaceutical products providing enhanced analgesia |
| US5099030A (en) | 1987-03-09 | 1992-03-24 | The Procter & Gamble Company | Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain |
| US5021450A (en) | 1989-05-30 | 1991-06-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof |
| US5431914A (en) | 1992-04-17 | 1995-07-11 | Adekunle; Michael | Method of treating an internal condition by external application of capsaicin without the need for systemic absorption |
| US5985860A (en) | 1992-06-03 | 1999-11-16 | Toppo; Frank | System for transdermal delivery of pain relieving substances |
| US5318960A (en) | 1992-06-03 | 1994-06-07 | Frank Toppo | System for transdermal delivery of pain relieving substances |
| EP0646372B1 (de) | 1993-09-30 | 1999-03-31 | Medichemie Ag | Capsaicin enthaltendes Arzneimittel zur Behandlung chronischer Rhinopathie |
| US5762963A (en) | 1995-06-07 | 1998-06-09 | Emory University | Method and compositions for controlling oral and pharyngeal pain using capsaicinoids |
| US6248788B1 (en) | 1996-11-06 | 2001-06-19 | The Regents Of The University Of California | Therapeutic method with capsaicin and capasicin analogs |
| WO1998020867A1 (en) | 1996-11-15 | 1998-05-22 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Pharmaceutical compositions containing vanilloid agonists in combination with vanilloid antagonists |
| US6060060A (en) | 1997-01-31 | 2000-05-09 | Bmb Patent Holding Corporation | Analgesic compositions from sweet peppers and methods of use thereof |
| ATE219674T1 (de) | 1997-03-13 | 2002-07-15 | James N Campbell | Zusammensetzung enthaltend capsaicin oder seine analogen und lokalanästhetika |
| EP0984781A1 (en) | 1997-05-27 | 2000-03-15 | Algos Pharmaceutical Corporation | Analgesic drug composition containing a capsaicinoid and potentiator therefor |
| CA2442049C (en) | 2001-03-22 | 2010-06-01 | Michael J. Iadarola | Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist |
| US20040146590A1 (en) | 2001-03-22 | 2004-07-29 | Iadarola Michael J | Molecular neurochirurgie for pain control administering locally capsaicin or resinferatoxin |
| US20030104085A1 (en) | 2001-12-05 | 2003-06-05 | Yeomans David C. | Methods and compositions for treating back pain |
| JP2005538983A (ja) | 2002-07-19 | 2005-12-22 | メステックス アクチエンゲゼルシャフト | 関節痛の治療のための薬剤を製造するための神経毒性物質の使用および同薬剤を適用する方法 |
| PT1605956E (pt) | 2002-12-18 | 2016-03-09 | Centrexion Therapeutics Corp | Administração de capsaicinóides para o tratamento da osteoartrite |
| US20040156931A1 (en) | 2002-12-18 | 2004-08-12 | Algorx | Administration of capsaicinoids |
| US7943166B2 (en) | 2003-04-10 | 2011-05-17 | Neurogesx, Inc. | Methods and compositions for administration of TRPV1 agonists |
| RU2373953C2 (ru) | 2003-12-19 | 2009-11-27 | Ново Нордиск Хелс Кеа Аг | Стабилизированная композиция, содержащая полипептид фактора vii |
| US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| EA200701131A1 (ru) * | 2004-11-24 | 2007-12-28 | Алгоркс Фармасьютикалз, Инк. | Гелеобразная препаративная форма капсаициноида и способы её применения |
| DE502004011941D1 (de) | 2004-12-22 | 2011-01-05 | Mestex Ag | Mischung eines vanilloidrezeptoragonisten mit einer nervenregenerationshemmenden substanz, ihre verwendung für die herstellung eines schmerzmittels und verfahren zur applikation dieses mittels |
| ES2533256T3 (es) | 2004-12-28 | 2015-04-08 | Mestex Ag | Uso de resiniferatoxina (RTX) para la fabricación de un medicamento para el tratamiento del dolor |
| EP1830835B1 (de) | 2004-12-28 | 2012-03-14 | Mestex AG | Verwendung eines vanilloidrezeptoragonisten zusammen mit einem glycosaminoglycan oder proteoglycan f]r die herstellung eines mittels zur behandlung von gelenkschmerzen und verfahren zur applikation dieses mittels |
| EP1865933B1 (en) * | 2005-03-30 | 2015-11-04 | Vanderbilt Royalty Sub L.P. | Low-concentration capsaicin patch and methods for treating neuropathic pain |
| US20080160487A1 (en) | 2006-12-29 | 2008-07-03 | Fairfield Language Technologies | Modularized computer-aided language learning method and system |
| US8158682B2 (en) | 2008-09-12 | 2012-04-17 | Vallinex, Inc. | Instillation administration of capsaicinoids for the treatment of pain |
| CN101507818B (zh) | 2008-12-15 | 2010-11-10 | 中国人民武装警察部队医学院 | 辣椒碱β-环糊精包合物及包合物的脂质体及凝胶 |
| US8637569B2 (en) | 2009-10-22 | 2014-01-28 | Api Genesis, Llc | Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
| US20130303495A1 (en) | 2009-12-31 | 2013-11-14 | Sov Therapeutics | Emulsion formulations |
| EP2552302B1 (en) * | 2010-03-30 | 2020-07-01 | The Children's Research Institute | Apparatus and method for human algometry |
| EP3388057B1 (en) | 2011-09-09 | 2022-03-09 | Propella Therapeutics, Inc. | A pain relief composition, comprising a trpv1 selective agonist, and manufacture and uses thereof |
| US9566187B2 (en) | 2012-03-13 | 2017-02-14 | Breg, Inc. | Cold therapy systems and methods |
| CA2868416A1 (en) | 2012-04-18 | 2013-10-24 | Mallinckrodt Llc | Immediate release pharmaceutical compositions with abuse deterrent properties |
| ES2699806T3 (es) | 2012-04-18 | 2019-02-12 | SpecGx LLC | Composiciones farmacéuticas, disuasivas del abuso, de liberación inmediata |
| GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
| US11154535B2 (en) | 2012-07-31 | 2021-10-26 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
| JP2015523401A (ja) | 2012-08-03 | 2015-08-13 | メステックス・アー・ゲー | レシニフェラトキシン溶液 |
| AU2013341380B2 (en) | 2012-11-12 | 2018-04-26 | Propella Therapeutics, Inc. | Aqueous based capsaicinoid formulations, and treatment in combination with a corticosteroid |
| GB201304662D0 (en) | 2013-03-14 | 2013-05-01 | Sigmoid Pharma Ltd | Compositions |
| US9956166B2 (en) | 2013-09-18 | 2018-05-01 | Sorrento Therapeutics, Inc. | Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin |
| GB201317756D0 (en) | 2013-10-08 | 2013-11-20 | Critical Pharmaceuticals Ltd | New process |
| GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
| GB201319792D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
| US20150133561A1 (en) * | 2013-11-12 | 2015-05-14 | Vizuri Health Sciences Llc | Aqueous based capsaicinoid formulations and methods of manufacture and use |
| JP6487452B2 (ja) | 2014-01-24 | 2019-03-20 | センティス ファーマ プライベート リミテッド | ブリンゾラミドを含む医薬組成物 |
| US20170042834A1 (en) | 2014-04-14 | 2017-02-16 | Flex Pharma, Inc. | Ion channel activators and methods of use |
| MX377377B (es) | 2014-04-15 | 2025-03-10 | Propella Therapeutics Inc | Composiciones tópicas para el alivio del dolor, manufactura y uso. |
| CN105030760B (zh) | 2014-04-24 | 2018-10-02 | 长弘生物科技股份有限公司 | 稳定医药组合物 |
| JP6855248B2 (ja) | 2014-06-25 | 2021-04-07 | ヌカナ ピーエルシー | ゲムシタビン−プロドラッグを含む製剤 |
| WO2015198350A1 (en) | 2014-06-25 | 2015-12-30 | Synergia Bio Sciences Private Limited | A pharmaceutical oil-in-water nano-emulsion |
| KR20170066344A (ko) | 2014-08-19 | 2017-06-14 | 만디쇼라 이스라엘 무자리 | 약제로서의 캡시노이드 및 그의 용도 |
| JP2017534656A (ja) | 2014-11-13 | 2017-11-24 | セントレクシオン セラピューティクス コーポレイション | 肢端舐性肉芽腫の治療に使用するためのカプサイシノイド |
| US9359316B1 (en) | 2014-11-25 | 2016-06-07 | Concentric Analgesics, Inc. | Prodrugs of phenolic TRPV1 agonists |
| WO2016126540A1 (en) | 2015-02-02 | 2016-08-11 | Enspire Group LLC | Stabilized dialkyl fumarate compositions |
| CA2987517A1 (en) | 2015-05-29 | 2016-12-08 | Sun Pharmaceutical Industries Limited | Oral pharmaceutical composition of isotretinoin |
| CA3254279A1 (en) | 2015-06-03 | 2025-03-18 | Triastek, Inc. | PHARMACEUTICAL FORMS AND RELATED USES |
| WO2017087803A1 (en) | 2015-11-20 | 2017-05-26 | Sorrento Therapeutics, Inc. | Methods for pain treatment using resiniferatoxin |
| EP3405187A4 (en) | 2016-01-22 | 2019-07-31 | Centrexion Therapeutics Corporation | SEQUENCING DOSAGE METHOD FOR CAPSAICN FOR THE TREATMENT OF MORTON NEUROM |
| WO2017147146A1 (en) | 2016-02-23 | 2017-08-31 | Concentric Analgesics, Inc. | Prodrugs of phenolic trpv1 agonists |
| EP3463576A4 (en) | 2016-05-25 | 2020-01-15 | Concentric Analgesics, Inc. | PRODRUGS BY PHENOLIC TRPV1 AGONISTS IN COMBINATION WITH LOCAL ANESTHETIC AND VASOCONSTRICTORS FOR IMPROVED LOCAL ANESTHESIA |
| KR102657458B1 (ko) * | 2016-11-02 | 2024-04-12 | 센트렉시온 테라퓨틱스 코포레이션 | 안정한 수성의 캡사이신 주사 가능한 제형 및 이의 의학적 용도 |
| WO2018217937A1 (en) | 2017-05-24 | 2018-11-29 | Concentric Analgesics, Inc. | Prodrugs of phenolic trpv1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia |
| WO2019018769A1 (en) * | 2017-07-20 | 2019-01-24 | Centrexion Therapeutics Corporation | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN USING CAPSAICINE |
-
2018
- 2018-07-20 WO PCT/US2018/043094 patent/WO2019018769A1/en not_active Ceased
- 2018-07-20 IL IL272036A patent/IL272036B2/en unknown
- 2018-07-20 ES ES18834548T patent/ES3018268T3/es active Active
- 2018-07-20 AU AU2018302342A patent/AU2018302342B2/en active Active
- 2018-07-20 US US16/631,277 patent/US20200206166A1/en not_active Abandoned
- 2018-07-20 MX MX2020000488A patent/MX2020000488A/es unknown
- 2018-07-20 JP JP2020502343A patent/JP7282736B2/ja active Active
- 2018-07-20 CN CN201880055069.0A patent/CN111201015A/zh active Pending
- 2018-07-20 CA CA3069540A patent/CA3069540A1/en active Pending
- 2018-07-20 BR BR112020000989-0A patent/BR112020000989A2/pt unknown
- 2018-07-20 EP EP18834548.2A patent/EP3654961B1/en active Active
-
2020
- 2020-08-04 US US16/984,384 patent/US11026903B2/en active Active
-
2021
- 2021-06-04 US US17/339,414 patent/US12201594B2/en active Active
-
2023
- 2023-05-17 JP JP2023081213A patent/JP7738031B2/ja active Active
-
2024
- 2024-12-17 US US18/984,070 patent/US20250312298A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020527574A5 (https=) | ||
| JP6050902B2 (ja) | 即効型インスリン組成物 | |
| MX2007006253A (es) | Formulacion de gel de capsaicinoide y usos para esta. | |
| JP2019537589A5 (https=) | ||
| WO2016123270A1 (en) | Parenteral and topical compositions for pain | |
| KR20190101368A (ko) | 안정한 수성의 캡사이신 주사 가능한 제형 및 이의 의학적 용도 | |
| JP2023116457A (ja) | カプサイシンを使用した疼痛の治療のための方法及び組成物 | |
| RU2487707C2 (ru) | Применение парацетамола и ибупрофена в лечении | |
| EP2946777B1 (en) | Medicine for treatment of neuropathic disease | |
| CA2720987A1 (en) | Dosages and methods for the treatment of cancer | |
| TW201105341A (en) | Pharmacetical composition for inhibitng pain | |
| CN108354898B (zh) | 一种治疗类风湿性关节炎的透皮给药制剂及其制备方法 | |
| JP2019506397A5 (https=) | ||
| JP2014522414A5 (https=) | ||
| Kuehhas et al. | Peyronie’s disease: nonsurgical therapy options | |
| Teasell et al. | Reflex sympathetic dystrophy involving three limbs: a case study | |
| CN1233316C (zh) | 阿魏提取物的制药用途 | |
| JP2022185071A (ja) | 関節疾患処置用組成物およびこれを含むキット | |
| US11813237B2 (en) | Creatine, its derivatives, compositions and methods of use thereof | |
| CN101677943B (zh) | 使用苯甲醇的多剂量浓缩艾司洛尔 | |
| CN106413700B (zh) | 外用药物组合物 | |
| JPWO2020041658A5 (https=) | ||
| CN112472667B (zh) | 一种维他昔布长效注射液及其制备方法和应用 | |
| JP7229013B2 (ja) | 内服用医薬組成物 | |
| CN107233307A (zh) | 一种布洛芬注射液及其制备方法 |